BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 16, 2026
Breaking News: Tracking hantavirus across the globe
Breaking News: Tracking hantavirus across the globe
Breaking News: Tracking hantavirus across the globe
Home
»
Topics
» BioWorld Science, Nephrology
BioWorld Science, Nephrology
RSS
Nymox provides update on pivotal phase III NX-1207 trials for BPH
Feb. 12, 2010
FYO-750 improves bladder capacity in neurogenic detrusor overactivity in rats
Feb. 11, 2010
3SBio and Panacor sign agreement to develop and commercialize Nephoxil in China
Feb. 11, 2010
Palatin Technologies doses first male cohort in bremelanotide safety trial
Feb. 10, 2010
European Commission grants marketing authorization for silodosin in BPH
Feb. 8, 2010
Recordati receives European approval for silodosin for BPH
Feb. 4, 2010
Vantia's VA-106483 enters phase IIb trial for nocturia
Feb. 4, 2010
Spectrum terminates development of ozarelix for benign prostate hypertrophy
Jan. 28, 2010
Protox Therapeutics presents phase IIb trial results on PRX-302 in BPH
Jan. 14, 2010
Reata and Kyowa Hakko Kirin sign licensing agreement for CKD drug bardoxolone
Jan. 12, 2010
Previous
1
2
…
132
133
134
135
136
137
138
139
140
…
328
329
Next